PhalconBio Secures £1 Million PACE Grant February 22, 2025 PACE (Pathways to Antimicrobial Clinical Efficacy) is one of the UK’s largest public-private initiatives targeting early-stage antimicrobial medicines and diagnostic discovery. PACE helps to…
Discovery: Dual Functionality of Phage Anti-CRISPR Protein Unveiled July 10, 2024 Recently published research has made significant strides in understanding the complex interactions between bacteria and the viruses that infect them, known as phages. This…
Study Unveils Viral Resilience Against Bacterial Restriction and Modification Mechanisms December 12, 2023 In the microscopic battlefield of microbial warfare, bacteriophages emerge as natural adversaries and “predators” of bacteria, demonstrating a remarkable ability to target specific bacterial…
Cell free synthesis of bacteriophages proved more efficient October 13, 2023 Many people are now familiar with phage therapy, a fascinating approach that harnesses viruses to combat drug-resistant bacteria. While this therapy boasts numerous benefits,…
Unveiling the Remarkable Arsenal of Antiphage Defense Systems in Bacteria July 18, 2023 Did you know that bacteria have developed incredibly diverse and fascinating defense systems to protect themselves against viruses known as phages? These defense mechanisms,…
